JP Patent

JP6162125B2 — 神経変性障害を処置するためのウリジン二リン酸誘導体、組成物および方法

Assigned to タフツ・ユニバーシティ · Expires 2017-07-12 · 9y expired

What this patent protects

Patent listed against Briviact.

Drugs covered by this patent

Patent Metadata

Patent number
JP6162125B2
Jurisdiction
JP
Classification
—
Expires
2017-07-12
Drug substance claim
No
Drug product claim
No
Assignee
タフツ・ユニバーシティ
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.